2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Breeze Acquisition Corp. II's Audit Committee concluded on August 28, 2026 that the audited balance sheet as of May 14, 2026, included in a June 2, 2026 Form 8-K, should no longer be relied upon due to an accounting error tied to legal advisor fees. The company also reported a material weakness in internal controls over contract review and said it disbursed cash under an obligation that did not exist.
The Audit Committee made the conclusion on August 28, 2026, after discussion with the company's auditor, CBIZ CPAs P.C.
The restatement removes $1,957,000 of accrued expenses and $93,000 of additional paid-in capital, and reclassifies the $1,150,000 cash payment as a receivable due from the Sponsor.
The company identified a material weakness in internal control over financial reporting and is implementing remediation procedures.
Restated financial statements are to be filed in an amendment to this Form 8-K and in the Form 10-Q for the quarter ended June 30, 2026.
On August 26, 2026, RenX Enterprises sold $5,662,716.07 in second senior convertible notes and second warrants in a private placement, with net proceeds of about $5.4 million after fees. The company used the proceeds to repay its February notes at 110% of their outstanding principal, and amended the related agreements to change registration deadlines and liquidated damages terms. The filing shows added debt and potential dilution from conversion and warrant shares, though it does not state a financial result.
Second Notes principal of $5,662,716.07 issued August 26, 2026; net proceeds of about $5.4 million
Up to 11,664,772 shares issuable on conversion at the Floor Price, and 3,520,859 shares under Second Warrants
Proceeds used to repay February Notes at 110% of outstanding principal
Second Registration Statement due 15th calendar day after the Second Closing Date
AiRWA Inc. (Nasdaq: YYAI) received a Nasdaq letter on August 24, 2026, saying it breached a listing rule by not filing its annual report on Form 10-K for the year ended April 30, 2026. The company blamed the delay on the time needed to consolidate a significant acquired business, and says the notice has no immediate effect on trading but that the filing and compliance are not assured.
Nasdaq letter dated August 24, 2026 cites Listing Rule 5250(c)(1) for the late 10-K.
Company must submit a compliance plan by October 23, 2026; Nasdaq may then grant an extension to January 25, 2027.
Company expects to file the 10-K before October 23, 2026, but the filing says there can be no assurance it will regain compliance.
Oragenics said NYSE American notified it on August 26, 2026 that it is below the continued listing standards for stockholders' equity. The company reported stockholders' equity of $3.7 million at June 30, 2026, and the exchange requires $6 million because the company had net losses in its five most recent fiscal years. The notice does not immediately affect the listing, but if the company does not meet the requirements, it could face delisting, which the filing says could reduce the stock's liquidity and market price.
Stockholders' equity was $3.7 million at June 30, 2026; the NYSE American standard cited requires $6 million.
A compliance plan is due to NYSE American by September 25, 2026, and the company must regain compliance by February 25, 2028.
Shares continue to trade as OGEN with a ".BC" (below compliance) designation during the plan period.
The company says it will endeavor to undertake a transaction in the future to achieve compliance, but gives no assurance it will succeed.
Socket Mobile received a Nasdaq notice dated August 24, 2026, saying it no longer meets the $2.5 million minimum stockholders' equity requirement, based on $2,382,624 reported in its June 30, 2026 quarterly report. The company must submit a compliance plan by October 8, 2026, and its stock continues to trade on the Nasdaq Capital Market under SCKT for now.
Stockholders' equity of $2,382,624 versus a $2.5 million Nasdaq minimum
Company also did not meet alternative standards: $35 million market value of listed securities or $500,000 net income from continuing operations
Compliance plan due October 8, 2026; Nasdaq may grant up to 180 calendar days if it accepts the plan
No immediate effect on listing or trading of SCKT common stock
Norwood Financial Corp's board adopted a stock repurchase program of up to 550,000 shares, about 5% of its issued and outstanding common stock, announced August 28, 2026. The program replaces the repurchase plan the company authorized in 2021, and the filing says repurchases will be made at management's discretion and may be suspended or terminated at any time.
Program covers up to 550,000 shares, approximately 5% of issued and outstanding common stock
Replaces and supersedes the repurchase plan authorized in 2021
Purchases may be made in open market or private transactions, through block trades, or under a Rule 10b5-1 trading plan
The company is not obligated to buy any particular number of shares and may suspend or modify the program at any time
Energy Fuels said its subsidiary completed the acquisition of all ordinary shares of Australian Strategic Materials Limited (ASM) on August 28, 2026, under a scheme implementation deed. The total scheme consideration was about $243.4 million, including $217.2 million in Energy Fuels shares and about $26.2 million in cash, and the company issued 14,808,572 common shares to ASM shareholders, which dilutes existing holders.
Scheme consideration per ASM share: 0.053 Energy Fuels shares (or CHESS Depositary Interests) plus AUS$0.13 in cash
Total consideration about $243.4 million: $217.2 million in shares and about $26.2 million in cash
14,808,572 unregistered Energy Fuels common shares issued on August 28, 2026, under Section 3(a)(10) exemption
ASM option holders received A$0.50 per option under a concurrent scheme
GeoVax Labs received a Nasdaq Staff Determination Letter on August 27, 2026, stating Nasdaq will delist its common stock because the bid price stayed below $1.00 and the company is not eligible for the customary 180-day compliance period after its January 2026 reverse split. The company plans to request a hearing before the Nasdaq Hearings Panel, which would stay further action and keep the stock trading during the appeal, but the filing says there is no assurance the panel will grant continued listing.
Nasdaq determined the closing bid price was below $1.00 for 30 consecutive business days from July 16, 2026 through August 26, 2026.
The company effected a 1-for-25 reverse stock split on January 12, 2026, which made it ineligible for the 180-day compliance period.
Absent a timely hearing request, trading is expected to be suspended at the opening of business on September 8, 2026; the hearing request deadline is September 3, 2026.
Karman Holdings completed its previously announced acquisition of Walker Precision Engineering for approximately $95 million, or £70 million, in cash, subject to customary adjustments. To help fund the deal, the company increased its term loans by $100 million under a Sixth Amendment to its Credit Agreement, bringing total original term loan principal to $863,961,000. The filing gives no financial results for Walker or for Karman, so its effect on earnings cannot be assessed from this document.
Acquisition of Walker closed August 28, 2026, through a wholly owned subsidiary for about $95 million (£70 million) in cash
Sixth Amendment to the Credit Agreement, dated August 26, 2026, increased term loans by $100,000,000 to a total original principal of $863,961,000
Walker supplies missile seekers, guidance systems and control systems on more than 25 EU tactical missile, air and defense programs
Karman has 17 locations across eight U.S. states; the deal adds a European footprint
My Size, Inc. received a Nasdaq letter on August 25, 2026, saying its stockholders' equity of $2,347,000 as of June 30, 2026 fell short of the $2,500,000 minimum for continued listing. The letter has no immediate effect on the listing, but the company must submit a compliance plan by October 9, 2026, and the Staff may grant an extension through February 21, 2027 if the plan is accepted.
Reported stockholders' equity as of June 30, 2026: $2,347,000 versus a $2,500,000 minimum under Nasdaq Listing Rule 5550(b)(1)
Compliance plan due October 9, 2026; the company plans to submit it on time
If accepted, extension possible through February 21, 2027; if not accepted or compliance is not regained, Staff would issue a delisting determination, which a hearing request would stay
Pinterest's Chief Financial Officer, Julia Brau Donnelly, resigned to pursue another opportunity and will stay until October 30, 2026. The company named Vikram Naidu, its current Vice President, Finance and Business Operations, as interim Principal Financial Officer effective the same day, and has started an external search for a permanent successor.
Donnelly submitted her resignation on August 26, 2026; the company says it is not the result of any disagreement on operations, policies or accounting.
Donnelly remains with Pinterest until October 30, 2026 to support an orderly transition.
Vikram Naidu, age 40, becomes interim Principal Financial Officer effective October 30, 2026, in addition to his current role; he has been Vice President, Finance and Business Operations since March 2024.
Pinterest has commenced an external search to identify a successor to Donnelly.
Lindsay Corporation's board appointed Alicia Pfeifer and Brett Coburn as interim co-Chief Financial Officers, effective September 1, 2026, with Coburn also serving as interim principal financial officer for SEC reporting. The filing describes a change in the company's finance leadership, and a $10,000 monthly stipend for each co-CFO while they hold the added responsibilities.
Alicia Pfeifer, 41, Vice President, Business Finance, and Brett Coburn, 35, Vice President and Chief Accounting Officer, named interim co-CFOs effective September 1, 2026
Coburn also serves as interim principal financial officer for SEC reporting purposes
Each receives an incremental $10,000 per month stipend while holding the co-CFO responsibilities
Pfeifer has been with the company since October 2014; Coburn since April 2019
Peabody Energy said its Executive Vice President and Chief Operating Officer, Darren R. Yeates, will move to a consulting agreement starting February 1, 2027, when his current employment contract expires, running through January 31, 2028. The move is part of the company's ongoing succession planning, and the filing sets out a fixed consulting fee that the company can end at any time.
Consulting agreement signed August 27, 2026; services begin February 1, 2027 and run through January 31, 2028
Minimum monthly consulting fee of $89,773, with up to 40 hours of services per month
Additional fee of $2,244 per hour for work beyond 40 hours in a month
PTC Therapeutics entered an asset purchase agreement on August 25, 2026 to acquire ST-920, an AAV gene therapy candidate for Fabry disease, from bankrupt Sangamo Therapeutics. The deal carries a $111 million upfront payment plus up to $100 million in contingent milestones tied to FDA approval, and closing requires Bankruptcy Court approval, which is scheduled for a hearing on September 10, 2026.
Upfront payment of $111 million, plus up to $100 million in contingent milestones ($80 million on accelerated approval and $20 million on full approval)
Acquisition is subject to Bankruptcy Court approval (hearing scheduled September 10, 2026) and Hart-Scott-Rodino waiting period expiration
Either party may terminate if closing has not occurred by October 15, 2026, subject to specified exceptions
Representations and warranties do not survive closing and there is no indemnification for breaches
Nasdaq staff determined to delist Jupiter Neurosciences' common stock from the Nasdaq Capital Market after the company did not regain compliance with the $35,000,000 minimum market value of listed securities by August 25, 2026. The company intends to appeal to the Nasdaq Hearings Panel and expects the hearing request to stay further action, but it cannot assure that the appeal will succeed. Separately, the company regained compliance with the $1.00 minimum bid price requirement, though the delisting threat remains.
Nasdaq notice received August 27, 2026 states the Staff determined to delist the common stock from The Nasdaq Capital Market.
Market value of listed securities was below the $35,000,000 minimum; the compliance deadline was August 25, 2026.
Company intends to request a hearing before the Nasdaq Hearings Panel and expects this to stay further action; success is not assured.
Closing bid price was at least $1.00 for 10 consecutive business days, August 13 through August 26, 2026, and the bid price matter is closed.
UniFirst said Executive Vice President and Chief Operating Officer Kelly Rooney has resigned to pursue other career opportunities, with her final day expected in mid to late September 2026. The filing says her departure is not the result of any disagreement with the company, and she will receive no severance-related payments because the departure is voluntary.
Kelly Rooney notified UniFirst on August 24, 2026 of her resignation as EVP and Chief Operating Officer
Final day of employment expected mid to late September 2026
No severance-related payments or benefits, as the resignation is voluntary
Steve Chikerotis and Brian Vollant, both Senior Vice Presidents, Operations, will oversee operations on an interim basis, reporting to CEO Steven Sintros
KALA BIO received a Nasdaq Staff Determination Letter on August 27, 2026, stating its common stock closed below $1.00 for 30 consecutive business days and it is out of compliance with the minimum bid price rule. Because the company effected a 1-for-50 reverse stock split on May 11, 2026, it is not eligible for a standard 180-day compliance period, and the company plans to request a Nasdaq Hearings Panel review, which would stay any delisting action while pending.
Nasdaq Staff determined the stock closed below $1.00 from July 16, 2026 through August 26, 2026, 30 consecutive business days.
No 180-day compliance period is available because the company effected a 1-for-50 reverse stock split on May 11, 2026.
KALA BIO intends to timely request a hearing before the Nasdaq Hearings Panel; a timely request stays suspension or delisting pending the Panel's decision.
The company states there is no assurance the Panel will grant continued listing or that it will regain compliance.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.